Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Implications of regulatory T cells in anti-cancer immunity: from pathogenesis to therapeutics. | Heliyon | 2022 | 36082331 | PubTator, text mining | PubMed |
| An integrative analysis revealing POLD2 as a tumor suppressive immune protein and prognostic biomarker in pan-cancer. | Front Genet | 2022 | 36081989 | PubTator, text mining | PubMed |
| BTLA inhibition has a dominant role in the cis-complex of BTLA and HVEM. | Front Immunol | 2022 | 36081508 | PubTator, text mining | PubMed |
| Current Progress of CAR-NK Therapy in Cancer Treatment. | Cancers (Basel) | 2022 | 36077853 | PubTator, text mining | PubMed |
| Immunization Combined with Ferroptosis Related Genes to Construct a New Prognostic Model for Head and Neck Squamous Cell Carcinoma. | Cancers (Basel) | 2022 | 36077637 | PubTator, text mining | PubMed |
| A humanized 4-1BB-targeting agonistic antibody exerts potent antitumor activity in colorectal cancer without systemic toxicity. | J Transl Med | 2022 | 36076251 | PubTator, text mining | PubMed |
| Tumor targeted 4-1BB agonist antibody-albumin fusions with high affinity to FcRn induce anti-tumor immunity without toxicity. | iScience | 2022 | 36072551 | PubTator, text mining | PubMed |
| Tumor-associated macrophages in liver cancer: From mechanisms to therapy. | Cancer Commun (Lond) | 2022 | 36069342 | PubTator, text mining | PubMed |
| Methamphetamine induces transcriptional changes in cultured HIV-infected mature monocytes that may contribute to HIV neuropathogenesis. | Front Immunol | 2022 | 36059515 | PubTator, text mining | PubMed |
| Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy. | Trends Immunol | 2022 | 36058806 | PubTator, text mining | PubMed |
| Construction and evaluation of a prognostic risk model of tumor metastasis-related genes in patients with non-small cell lung cancer. | BMC Med Genomics | 2022 | 36056349 | PubTator, text mining | PubMed |
| An immune-related microRNA signature prognostic model for pancreatic carcinoma and association with immune microenvironment. | Sci Rep | 2022 | 36056032 | PubTator, text mining | PubMed |
| Integrated analysis of necroptosis-related lncRNAs for prognosis and immunotherapy of patients with pancreatic adenocarcinoma. | Front Genet | 2022 | 36051690 | PubTator, text mining | PubMed |
| Pan-cancer analysis suggests histocompatibility minor 13 is an unfavorable prognostic biomarker promoting cell proliferation, migration, and invasion in hepatocellular carcinoma. | Front Pharmacol | 2022 | 36046831 | PubTator, text mining | PubMed |
| Advances in Takayasu arteritis: An Asia Pacific perspective. | Front Med (Lausanne) | 2022 | 36045929 | PubTator, text mining | PubMed |
| Study of The Correlation between miR-106a, miR-125b, and miR-330 on Multiple Sclerosis Patients by Targeting TNFSF4 and SP1 in NF-кb/TNF-α Pathway: A Case-Control Study. | Cell J | 2022 | 36043408 | PubTator, text mining | PubMed |
| Identification and validation of a novel prognostic model of inflammation-related gene signature of lung adenocarcinoma. | Sci Rep | 2022 | 36042374 | PubTator, text mining | PubMed |
| Inflammatory aging clock: A cancer clock to characterize the patients' subtypes and predict the overall survival in glioblastoma. | Front Genet | 2022 | 36035122 | PubTator, text mining | PubMed |
| Potential of histone deacetylase inhibitors in the control and regulation of prostate, breast and ovarian cancer. | Front Chem | 2022 | 36034650 | PubTator, text mining | PubMed |
| mRNA vaccines in the prevention and treatment of diseases. | MedComm (2020) | 2022 | 36033422 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=41